MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] --
 QUICK SEARCH:   [advanced]


     


Molecular Pharmacology Fast Forward
First published on July 31, 2008; DOI: 10.1124/mol.108.047068


This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
mol.108.047068v1
74/5/1367    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Google Scholar
Right arrow Articles by Lin, B. C
Right arrow Articles by Bradfield, C. A
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lin, B. C
Right arrow Articles by Bradfield, C. A


Received for publication March 7, 2008.
Revised July 30, 2008.
Accepted for publication July 31, 2008.

A Hypomorphic Allele of Aryl-hydrocarbon Receptor-associated-9 Produces a Phenocopy of the Ahr Null

Bernice C Lin 1, Linh P Nguyen 1, Jacqueline A Walisser 1, Christopher A Bradfield 1*

1 McArdle Laboratories

* Address correspondence to: E-mail: bradfield{at}oncology.wisc.edu

Abstract

The aryl hydrocarbon receptor associated protein-9 (ARA9) is a chaperone of the aryl hydrocarbon receptor (AHR). The AHR has been shown to play a late developmental role in the normal closure of a fetal hepato-vascular shunt known as the ductus venosus (DV). Given that Ara9 null mice display early embryonic lethality, we generated a hypomorphic Ara9 allele (designated Ara9fxneo) that displays reduced ARA9 protein expression. In an effort to demonstrate the role of ARA9 protein in AHR-mediated DV closure, we used combinations of Ara9 wildtype (Ara9+/+), null (Ara9-/-) and hypomorphic (Ara9fxneo) alleles to produce mice with a graded expression of the ARA9 protein. Liver perfusion studies demonstrated that while none of the Ara9+/+ mice displayed a patent DV, the shunt was observed in 10% of the Ara9+/fxneo mice, 55% of the Ara9+/+ mice and 83% of the Ara9fxneo/fxneo mice. That expression level of ARA9 correlates with the frequency of a phenocopy of the Ahr null allele supports the conclusion that the ARA9 protein is essential for AHR signaling during development.


Key words: Cytochrome P450, Ah receptor, Toxicant-induced gene express





Home Help [Feedback] [For Subscribers] [Archive] [Search] --
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2008 by the American Society for Pharmacology and Experimental Therapeutics